StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 165.00
0.00 (0.00%)
Oct 6, 2026, 3:30 PM JST
StemRIM Market Cap
StemRIM has a market cap or net worth of 10.34 billion as of October 5, 2026. Its market cap has decreased by -42.60% in one year.
Market Cap
10.34B
Enterprise Value
4.97B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
165.00
ChartMarket Cap Chart
Since August 9, 2019, StemRIM's market cap has decreased from 49.82B to 10.34B, a decrease of -79.24%. That is a compound annual growth rate of -19.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 10.34B | -37.26% |
| Dec 30, 2025 | 16.49B | -15.37% |
| Dec 30, 2024 | 19.48B | -45.16% |
| Dec 29, 2023 | 35.52B | -34.08% |
| Dec 30, 2022 | 53.89B | 3.59% |
| Dec 30, 2021 | 52.02B | 40.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ReproCELL | 14.22B |
| Immuno-Biological Laboratories | 10.77B |
| Kubota Pharmaceutical Holdings | 10.54B |
| K Pharma,Inc. | 8.87B |
| Carna Biosciences | 8.82B |
| Nano Holdings | 8.71B |
| CellSeed | 8.49B |
| Kidswell Bio | 8.40B |